Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center

被引：0
|
作者：
Qingwei Zhu
Wei Rao
Junyu Huo
Zixiang Li
Song Wang
Wensheng Qiu
Ge Guan
Yang Xin
Ning Fan
Jinzhen Cai
Liqun Wu
机构：
[1] The Affiliated Hospital of Qingdao University,Liver Disease Center
[2] The Affiliated Hospital of Qingdao University,Department of Interventional Medicine Cancer Hospital
[3] Tumor Hospital,undefined
[4] The Affiliated Hospital of Qingdao University,undefined
来源：
BMC Gastroenterology | / 23卷
关键词：
Hepatocellular carcinoma; Regorafenib; Combination therapy; Real-world research;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center
    Zhu, Qingwei
    Rao, Wei
    Huo, Junyu
    Li, Zixiang
    Wang, Song
    Qiu, Wensheng
    Guan, Ge
    Xin, Yang
    Fan, Ning
    Cai, Jinzhen
    Wu, Liqun
    [J]. BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [2] Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Lee, Min Jin
    Chang, Sung Won
    Kim, Ji Hoon
    Lee, Young-Sun
    Cho, Sung Bum
    Seo, Yeon Seok
    Yim, Hyung Joon
    Hwang, Sang Youn
    Lee, Hyun Woong
    Chang, Young
    Jang, Jae Young
    [J]. INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 260 - 268
  • [3] Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Min Jin Lee
    Sung Won Chang
    Ji Hoon Kim
    Young-Sun Lee
    Sung Bum Cho
    Yeon Seok Seo
    Hyung Joon Yim
    Sang Youn Hwang
    Hyun Woong Lee
    Young Chang
    Jae Young Jang
    [J]. Investigational New Drugs, 2021, 39 : 260 - 268
  • [4] The real-world systemic sequential therapy of sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Lee, Yoonseok
    Chang, Sung Won
    Lee, Min-Jin
    Kim, Ji Hoon
    Bang, Soo Min
    Kim, Sehwa
    Lee, Young-Sun
    Cho, Sung Bum
    Seo, Yeon Seok
    Yim, Hyung Joon
    Hwang, Sang Youn
    Lee, Hyun Woong
    Chang, Young
    Jang., Jae Young
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S909 - S909
  • [5] Efficacy and safety of radiotherapy combined with regorafenib for advanced hepatocellular carcinoma: A real-world study from a single center
    Xin, Lingxia
    Wang, Liming
    Zhai, Yirui
    Wang, Shulian
    Tang, Yuan
    Liu, Yueping
    Song, Yongwen
    Fang, Hui
    Li, Ning
    Qi, Shunan
    Lu, Ningning
    Li, Ye-Xiong
    Chen, Bo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis
    Leyh, Catherine
    Ehmer, Ursula
    Roessler, Daniel
    Philipp, Alexander B.
    Reiter, Florian P.
    Jeliazkova, Petia
    Jochheim, Leonie S.
    Jeschke, Matthias
    Hammig, Janina
    Ludwig, Johannes M.
    Theysohn, Jens M.
    Geier, Andreas
    Lange, Christian M.
    [J]. CANCERS, 2022, 14 (08)
  • [7] Comparative efficacy of systemic sequential regorafenib after sorafenib or lenvatinib treatment failure for advanced hepatocellular carcinoma: A retrospective, multi-center, real-world study
    Song, D.
    Zheng, L.
    Zhang, A.
    Cao, F.
    Hao, W.
    Zhao, Z.
    Zheng, J.
    Lu, D.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S615 - S615
  • [8] Efficacy and safety of regorafenib and/or immune checkpoint inhibitors as a second-line therapy for advanced hepatocellular carcinoma: A real-world study from a single center.
    Liu, Songtao
    Huang, Xueying
    Chen, Jingjing
    Wei, Qiaoxin
    Liu, Mei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Real-world evidence of multi-systemic therapy for hepatocellular carcinoma
    Aikata, Hiroshi
    Yamauchi, Masami
    Ono, Atsushi
    Miki, Daiki
    Tsuge, Masataka
    Chayama, Kazuaki
    [J]. CANCER SCIENCE, 2021, 112 : 1066 - 1066
  • [10] Immunotherapy combination with regorafenib for refractory hepatocellular carcinoma: A real-world study
    Tu, Xinyue
    Yang, Jing
    Zheng, Yingbin
    Liang, Chen
    Tao, Qiang
    Tang, Xiang
    Liu, Zonghao
    Jiang, Lingmin
    He, Zhaoqian
    Xie, Feihu
    Zheng, Yun
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
12345